167 Mapping opportunities and threats for the future demand of red blood cells in the Netherlands Table S1: Overview of the opportunities, threats, and mitigating measures per theme (indepth version of Table 3 in the main manuscript) (Continued) 8. Societal context - This includes opportunities and threats related to social capital, political, and economical factors. Opportunities • Blood donors willing to donate much more than blood • Society has enhanced appreciation of blood donation Threats • Society values other charitable activities other than blood donation • Politics cut resources or decides to commercialize blood banking • Availability of research money declines • Societal movement advocating that every human has the right to donate blood or plasma so that blood donation eligibility criteria is disregarded Mitigating measures • Sanquin takes intentional political actions, such as lobbying in political spheres, connecting with politicians and developing ‹political will,› having collaborations with EU health organizations • Launch a public campaign that incorporates: 1. Customized recruitment and retention materials per age group/generation (adopt strategies from commercialized companies) even using politicians or known figures; 2. Clearly explains Sanquin’s story and value, and how it differentiates from other countries; 3. Explanation of parts of the transfusion chain, including research; 4. Shows our charitable involvement 9. Changing legislation - This includes opportunities and threats related to legislation, especially to opening of borders and privacy laws. Opportunity and threat: • Legislation of open borders leading to: • Blood banks in different countries can be merged or have certain production processes merged/shared • Dutch hospitals having freedom to buy foreign blood products Threats: • GDPR/AVG hinders donor research • GDPR/AVG interest may conflict with donor and patient interests Mitigating measures Sanquin creates an adaptive policy (which can be amended as change happens) which includes: 1. Updating operational protocols and plans to make it flexible to change, 2. Ensuring contingency planning with other EU countries for open borders, 3. Solidifying political connections with European Medicines Agency, European Blood Alliance, German and Belgian politicians and blood bankers 4. Having mechanisms to lobby, as needed • Sanquin has visionary legal staff who can scan future developments and their implications for the organization, and be proactive in safeguarding Sanquin’s interests (through lobbying for example) • Sanquin’s legal department monitor GDPR and collaborate with research departments to find a way research and its operations can keep moving forward • Applying the balance between application of GDPR and operational processes by adopting the different perspectives of various donors; Use this balance for the benefit of a competitive edge
RkJQdWJsaXNoZXIy MTk4NDMw